X
<

Abbott Laboratories 3Q17 Earnings: What's Expected

PART:
1 2 3 4
Part 3
Abbott Laboratories 3Q17 Earnings: What's Expected PART 3 OF 4

What to Expect from Abbott Laboratories’ 3Q17 Earnings

Analysts’ estimates

The Health Care Select Sector SPDR Fund (XLV) has ~2.5% of its total holdings in Abbott Laboratories (ABT). The company is set to release its 3Q17 earnings results on October 18, 2017.

In 2Q17, ABT reported EPS (earnings per share) of $0.62, compared with the analysts’ estimates of 0.61 per share. ABT stock gained ~4% after the announcement on July 20, 2017.

What to Expect from Abbott Laboratories’ 3Q17 Earnings

Interested in ABT? Don't miss the next report.

Receive e-mail alerts for new research on ABT

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

According to the Wall Street analysts’ estimates, the 3Q17 EPS estimate for Abbott Laboratories is $0.65. Abbott Laboratories has provided an EPS guidance range of $0.64–$0.66 for 3Q17.

Margin estimates

According to the Wall Street analysts’ projections, Abbott Laboratories is expected to report a gross profit margin of 59.6% of total sales. In 2Q17, the gross profit margin of the company came in at ~59.8% of total sales.

ABT’s adjusted research and development investment is expected to be ~7.5% of sales in 3Q17. However, its adjusted SG&A (selling, general, and administrative) expenditure is expected to be 29% of total sales, compared with its SG&A expenses of 30.1% of sales reported in 2Q17.

Abbott’s major competitors Becton, Dickinson (BDX), Thermo Fisher Scientific (TMO), and Medtronic (MDT) are expected to register YoY (year-over-year) EPS growth of 11.9%, 10.8%, and -14.4%%, respectively.

In the next and final part of this series, we’ll take a look at Abbott’s 3Q17 sales outlook by business segment.

X

Please select a profession that best describes you: